Target intelligence / Profile preview

Activated platelet phospholipid membrane

Molecular classification
Phospholipid membrane, Other
01

Overview

Activated platelet phospholipid membrane surfaces refer to the specialized, procoagulant environment created when platelets undergo activation and lose their membrane asymmetry. In resting platelets, negatively charged phospholipids, primarily phosphatidylserine (PS), are actively maintained in the inner leaflet of the plasma membrane. Upon activation by agonists like thrombin or collagen, or during apoptosis, a process called "scrambling" occurs, translocating PS to the outer leaflet (Zwaal & Schroit, 1997). This exposed anionic surface acts as a critical template for the calcium-dependent binding of vitamin K-dependent clotting factors (Factors II, VII, IX, and X) via their gamma-carboxyglutamic acid (GLA) domains (Lentz, 2003). The assembly of the tenase (IXa-VIIIa) and prothrombinase (Xa-Va) complexes on this surface increases the efficiency of thrombin generation by several thousand-fold compared to reactions in solution (Heemskerk et al., 2013). Because this surface is essential for the propagation phase of coagulation, it is a major site of action for anticoagulant therapies that target the enzymatic complexes formed there. Furthermore, the detection of these surfaces using Annexin V or specific assays serves as a biomarker for prothrombotic states and platelet activation (StatPearls, 2023).

Other names
Procoagulant phospholipid surfacePhosphatidylserine-exposed platelet membranePlatelet procoagulant surfaceAnionic phospholipid membrane
02

Mechanism of action

Provides a catalytic anionic surface for the assembly of the tenase and prothrombinase complexes, which are essential for the explosive generation of thrombin during the coagulation cascade.

03

Biological functions

Blood coagulationHemostasisApoptosisOther
04

Disease associations

Cardiovascular diseaseOther
05

Safety considerations

Bleeding riskHemorrhageThrombocytopenia
06

Interacting drugs

Rivaroxaban

6 more in the full profile.

07

Biomarkers

Procoagulant phospholipid activity (PPL) assayAnnexin V bindingFlow cytometric phosphatidylserine exposure

Beyond the preview

Go deeper on Activated platelet phospholipid membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activated platelet phospholipid membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call